Increased CD9 expression predicts favorable prognosis in human cancers: a systematic review and meta-analysis View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-09-07

AUTHORS

Hyun Min Koh, Bo Gun Jang, Dong Hui Lee, Chang Lim Hyun

ABSTRACT

BackgroundCD9 is implicated in cancer progression and metastasis by its role in suppressing cancer cell proliferation and survival. However, the prognostic and clinicopathological significance of CD9 expression is controversial. Therefore, the current meta-analysis was conducted to determine the prognostic and clinicopathological significance of CD9 expression in cancer patients.MethodsEligible studies were selected through database search of PubMed, Embase and Cochrane library up to April 5 2020. The necessary data were extracted from the included studies. Pooled hazard ratio (HR) and odds ratio (OR) with 95% confidence interval (CI) were calculated to evaluate the prognostic and clinicopathological significance of CD9 expression in cancer patients.ResultsA total of 17 studies consisting of 3456 cancer patients were included in this meta-analysis. An increased CD9 expression was significantly associated with a more favorable overall survival (OS) (HR 0.47, 95% CI 0.31–0.73, p = 0.001) and disease-free survival (DFS) (HR 0.48, 95% CI 0.30–0.79, p = 0.003). In subgroup analysis of cancer type, an increased CD9 expression was associated with increased OS in breast cancer and digestive system cancer, and with increased DFS in head and neck cancer and leukemia/lymphoma. Additionally, an increased CD9 expression significantly correlated with lower overall stage (OR 0.45, 95% CI 0.29–0.72, p = 0.001).ConclusionAn increased CD9 expression was associated with favorable survival in cancer patients suggesting that CD9 expression could be a valuable survival factor in cancer patients. More... »

PAGES

472

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12935-021-02152-y

DOI

http://dx.doi.org/10.1186/s12935-021-02152-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1140949069

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34493282


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.256681.e", 
          "name": [
            "Department of Pathology, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koh", 
        "givenName": "Hyun Min", 
        "id": "sg:person.01165545573.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165545573.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Jeju National University Hospital, Jeju, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.411842.a", 
          "name": [
            "Department of Pathology, Jeju National University School of Medicine, 15 Aran 13-gil, 63241, Jeju, Republic of Korea", 
            "Department of Pathology, Jeju National University Hospital, Jeju, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jang", 
        "givenName": "Bo Gun", 
        "id": "sg:person.0640426775.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640426775.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Jeju National University Hospital, Jeju, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.411842.a", 
          "name": [
            "Department of Pathology, Jeju National University Hospital, Jeju, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Dong Hui", 
        "id": "sg:person.010725430255.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010725430255.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Jeju National University Hospital, Jeju, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.411842.a", 
          "name": [
            "Department of Pathology, Jeju National University School of Medicine, 15 Aran 13-gil, 63241, Jeju, Republic of Korea", 
            "Department of Pathology, Jeju National University Hospital, Jeju, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hyun", 
        "givenName": "Chang Lim", 
        "id": "sg:person.01214235466.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214235466.15"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1477-7819-10-92", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030619935", 
          "https://doi.org/10.1186/1477-7819-10-92"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12935-018-0668-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1108017045", 
          "https://doi.org/10.1186/s12935-018-0668-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12935-018-0702-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110764630", 
          "https://doi.org/10.1186/s12935-018-0702-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6601015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003573546", 
          "https://doi.org/10.1038/sj.bjc.6601015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6601542", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033478383", 
          "https://doi.org/10.1038/sj.bjc.6601542"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6990499", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056647019", 
          "https://doi.org/10.1038/sj.bjc.6990499"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-09-07", 
    "datePublishedReg": "2021-09-07", 
    "description": "BackgroundCD9 is implicated in cancer progression and metastasis by its role in suppressing cancer cell proliferation and survival. However, the prognostic and clinicopathological significance of CD9 expression is controversial. Therefore, the current meta-analysis was conducted to determine the prognostic and clinicopathological significance of CD9 expression in cancer patients.MethodsEligible studies were selected through database search of PubMed, Embase and Cochrane library up to April 5 2020. The necessary data were extracted from the included studies. Pooled hazard ratio (HR) and odds ratio (OR) with 95% confidence interval (CI) were calculated to evaluate the prognostic and clinicopathological significance of CD9 expression in cancer patients.ResultsA total of 17 studies consisting of 3456 cancer patients were included in this meta-analysis. An increased CD9 expression was significantly associated with a more favorable overall survival (OS) (HR 0.47, 95% CI 0.31\u20130.73, p\u2009=\u20090.001) and disease-free survival (DFS) (HR 0.48, 95% CI 0.30\u20130.79, p\u2009=\u20090.003). In subgroup analysis of cancer type, an increased CD9 expression was associated with increased OS in breast cancer and digestive system cancer, and with increased DFS in head and neck cancer and leukemia/lymphoma. Additionally, an increased CD9 expression significantly correlated with lower overall stage (OR 0.45, 95% CI 0.29\u20130.72, p\u2009=\u20090.001).ConclusionAn increased CD9 expression was associated with favorable survival in cancer patients suggesting that CD9 expression could be a valuable survival factor in cancer patients.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12935-021-02152-y", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1030596", 
        "issn": [
          "1475-2867"
        ], 
        "name": "Cancer Cell International", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "21"
      }
    ], 
    "keywords": [
      "disease-free survival", 
      "cancer patients", 
      "overall survival", 
      "clinicopathological significance", 
      "CD9 expression", 
      "hazard ratio", 
      "pooled hazard ratio", 
      "favorable overall survival", 
      "confidence intervals", 
      "digestive system cancers", 
      "leukemia/lymphoma", 
      "cancer cell proliferation", 
      "favorable survival", 
      "favorable prognosis", 
      "ResultsA total", 
      "Cochrane Library", 
      "subgroup analysis", 
      "neck cancer", 
      "MethodsEligible studies", 
      "system cancers", 
      "breast cancer", 
      "patients", 
      "overall stage", 
      "systematic review", 
      "cancer types", 
      "cancer", 
      "cancer progression", 
      "survival factor", 
      "cell proliferation", 
      "human cancers", 
      "survival", 
      "database search", 
      "expression", 
      "EMBASE", 
      "prognosis", 
      "lymphoma", 
      "metastasis", 
      "PubMed", 
      "ConclusionAn", 
      "progression", 
      "significance", 
      "study", 
      "total", 
      "proliferation", 
      "review", 
      "head", 
      "interval", 
      "factors", 
      "role", 
      "ratio", 
      "search", 
      "stage", 
      "data", 
      "types", 
      "analysis", 
      "necessary data", 
      "library"
    ], 
    "name": "Increased CD9 expression predicts favorable prognosis in human cancers: a systematic review and meta-analysis", 
    "pagination": "472", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1140949069"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12935-021-02152-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34493282"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12935-021-02152-y", 
      "https://app.dimensions.ai/details/publication/pub.1140949069"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-10T10:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_881.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12935-021-02152-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12935-021-02152-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12935-021-02152-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12935-021-02152-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12935-021-02152-y'


 

This table displays all metadata directly associated to this object as RDF triples.

167 TRIPLES      22 PREDICATES      89 URIs      75 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12935-021-02152-y schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N6186f44243d74e0b9ab18dc5534613ff
4 schema:citation sg:pub.10.1038/sj.bjc.6601015
5 sg:pub.10.1038/sj.bjc.6601542
6 sg:pub.10.1038/sj.bjc.6990499
7 sg:pub.10.1186/1477-7819-10-92
8 sg:pub.10.1186/s12935-018-0668-y
9 sg:pub.10.1186/s12935-018-0702-0
10 schema:datePublished 2021-09-07
11 schema:datePublishedReg 2021-09-07
12 schema:description BackgroundCD9 is implicated in cancer progression and metastasis by its role in suppressing cancer cell proliferation and survival. However, the prognostic and clinicopathological significance of CD9 expression is controversial. Therefore, the current meta-analysis was conducted to determine the prognostic and clinicopathological significance of CD9 expression in cancer patients.MethodsEligible studies were selected through database search of PubMed, Embase and Cochrane library up to April 5 2020. The necessary data were extracted from the included studies. Pooled hazard ratio (HR) and odds ratio (OR) with 95% confidence interval (CI) were calculated to evaluate the prognostic and clinicopathological significance of CD9 expression in cancer patients.ResultsA total of 17 studies consisting of 3456 cancer patients were included in this meta-analysis. An increased CD9 expression was significantly associated with a more favorable overall survival (OS) (HR 0.47, 95% CI 0.31–0.73, p = 0.001) and disease-free survival (DFS) (HR 0.48, 95% CI 0.30–0.79, p = 0.003). In subgroup analysis of cancer type, an increased CD9 expression was associated with increased OS in breast cancer and digestive system cancer, and with increased DFS in head and neck cancer and leukemia/lymphoma. Additionally, an increased CD9 expression significantly correlated with lower overall stage (OR 0.45, 95% CI 0.29–0.72, p = 0.001).ConclusionAn increased CD9 expression was associated with favorable survival in cancer patients suggesting that CD9 expression could be a valuable survival factor in cancer patients.
13 schema:genre article
14 schema:inLanguage en
15 schema:isAccessibleForFree true
16 schema:isPartOf N0f84be54bd5e40209e5ee885d09c42f1
17 N685451e56cfd497cbf8e25c9428e5872
18 sg:journal.1030596
19 schema:keywords CD9 expression
20 Cochrane Library
21 ConclusionAn
22 EMBASE
23 MethodsEligible studies
24 PubMed
25 ResultsA total
26 analysis
27 breast cancer
28 cancer
29 cancer cell proliferation
30 cancer patients
31 cancer progression
32 cancer types
33 cell proliferation
34 clinicopathological significance
35 confidence intervals
36 data
37 database search
38 digestive system cancers
39 disease-free survival
40 expression
41 factors
42 favorable overall survival
43 favorable prognosis
44 favorable survival
45 hazard ratio
46 head
47 human cancers
48 interval
49 leukemia/lymphoma
50 library
51 lymphoma
52 metastasis
53 necessary data
54 neck cancer
55 overall stage
56 overall survival
57 patients
58 pooled hazard ratio
59 prognosis
60 progression
61 proliferation
62 ratio
63 review
64 role
65 search
66 significance
67 stage
68 study
69 subgroup analysis
70 survival
71 survival factor
72 system cancers
73 systematic review
74 total
75 types
76 schema:name Increased CD9 expression predicts favorable prognosis in human cancers: a systematic review and meta-analysis
77 schema:pagination 472
78 schema:productId N0b21f0dba0c642b7bb6fcb64dadd5632
79 N7585c8208b974b6bbc77818932b96184
80 N89816896cd99440f9efee2d9b8d62e93
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1140949069
82 https://doi.org/10.1186/s12935-021-02152-y
83 schema:sdDatePublished 2022-05-10T10:30
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher N31b27e0bac3644eca3d47d4afba5ace4
86 schema:url https://doi.org/10.1186/s12935-021-02152-y
87 sgo:license sg:explorer/license/
88 sgo:sdDataset articles
89 rdf:type schema:ScholarlyArticle
90 N08800bc03f0c486b8a1a5eea9d3623b9 rdf:first sg:person.010725430255.89
91 rdf:rest N166841cfef484b519811ab6bca08dfa9
92 N0b21f0dba0c642b7bb6fcb64dadd5632 schema:name dimensions_id
93 schema:value pub.1140949069
94 rdf:type schema:PropertyValue
95 N0f84be54bd5e40209e5ee885d09c42f1 schema:volumeNumber 21
96 rdf:type schema:PublicationVolume
97 N166841cfef484b519811ab6bca08dfa9 rdf:first sg:person.01214235466.15
98 rdf:rest rdf:nil
99 N31b27e0bac3644eca3d47d4afba5ace4 schema:name Springer Nature - SN SciGraph project
100 rdf:type schema:Organization
101 N58787bbb32b94888aacdd8229c04ba9d rdf:first sg:person.0640426775.09
102 rdf:rest N08800bc03f0c486b8a1a5eea9d3623b9
103 N6186f44243d74e0b9ab18dc5534613ff rdf:first sg:person.01165545573.57
104 rdf:rest N58787bbb32b94888aacdd8229c04ba9d
105 N685451e56cfd497cbf8e25c9428e5872 schema:issueNumber 1
106 rdf:type schema:PublicationIssue
107 N7585c8208b974b6bbc77818932b96184 schema:name pubmed_id
108 schema:value 34493282
109 rdf:type schema:PropertyValue
110 N89816896cd99440f9efee2d9b8d62e93 schema:name doi
111 schema:value 10.1186/s12935-021-02152-y
112 rdf:type schema:PropertyValue
113 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
114 schema:name Medical and Health Sciences
115 rdf:type schema:DefinedTerm
116 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
117 schema:name Oncology and Carcinogenesis
118 rdf:type schema:DefinedTerm
119 sg:journal.1030596 schema:issn 1475-2867
120 schema:name Cancer Cell International
121 schema:publisher Springer Nature
122 rdf:type schema:Periodical
123 sg:person.010725430255.89 schema:affiliation grid-institutes:grid.411842.a
124 schema:familyName Lee
125 schema:givenName Dong Hui
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010725430255.89
127 rdf:type schema:Person
128 sg:person.01165545573.57 schema:affiliation grid-institutes:grid.256681.e
129 schema:familyName Koh
130 schema:givenName Hyun Min
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165545573.57
132 rdf:type schema:Person
133 sg:person.01214235466.15 schema:affiliation grid-institutes:grid.411842.a
134 schema:familyName Hyun
135 schema:givenName Chang Lim
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214235466.15
137 rdf:type schema:Person
138 sg:person.0640426775.09 schema:affiliation grid-institutes:grid.411842.a
139 schema:familyName Jang
140 schema:givenName Bo Gun
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640426775.09
142 rdf:type schema:Person
143 sg:pub.10.1038/sj.bjc.6601015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003573546
144 https://doi.org/10.1038/sj.bjc.6601015
145 rdf:type schema:CreativeWork
146 sg:pub.10.1038/sj.bjc.6601542 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033478383
147 https://doi.org/10.1038/sj.bjc.6601542
148 rdf:type schema:CreativeWork
149 sg:pub.10.1038/sj.bjc.6990499 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056647019
150 https://doi.org/10.1038/sj.bjc.6990499
151 rdf:type schema:CreativeWork
152 sg:pub.10.1186/1477-7819-10-92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030619935
153 https://doi.org/10.1186/1477-7819-10-92
154 rdf:type schema:CreativeWork
155 sg:pub.10.1186/s12935-018-0668-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1108017045
156 https://doi.org/10.1186/s12935-018-0668-y
157 rdf:type schema:CreativeWork
158 sg:pub.10.1186/s12935-018-0702-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110764630
159 https://doi.org/10.1186/s12935-018-0702-0
160 rdf:type schema:CreativeWork
161 grid-institutes:grid.256681.e schema:alternateName Department of Pathology, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea
162 schema:name Department of Pathology, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea
163 rdf:type schema:Organization
164 grid-institutes:grid.411842.a schema:alternateName Department of Pathology, Jeju National University Hospital, Jeju, Republic of Korea
165 schema:name Department of Pathology, Jeju National University Hospital, Jeju, Republic of Korea
166 Department of Pathology, Jeju National University School of Medicine, 15 Aran 13-gil, 63241, Jeju, Republic of Korea
167 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...